Physician
Psychiatry
Dr. James L. Claghorn Jr., MD
|
|
Give Review
James L. Claghorn Jr. is an expert in the field of Psychiatry. He went to medical school at Albany Medical College. Doctor James L. Claghorn Jr., MD has written publications. He has 84 publications published with PubMed. The lastest paper is: 'Recent developments in antidepressant agents.'
Publications
- Long-term treatment with clozapine on aging mice.
- A double-blind comparison of paroxetine and placebo in the treatment of depressed outpatients.
- The risks and benefits of clozapine versus chlorpromazine.
- The Anxiety-depression syndrome.
- The behavioral pharmacology of oxypertine.
- The many faces of Anxiety in different age groups.
- When is a tranquillizer an antidepressant?
- Differential Drug effects on social and symptomatic behaviors.
- Zimeldine tolerability in comparison to amitriptyline and placebo: findings from a multicentre trial.
- A double-blind evaluation of zimelidine in comparison to placebo and amitriptyline in patients with major depressive Disorder.
- Cholinesterase enzymes in the blood of patients with Alzheimer''s disease.
- Pilot study of MK-462 in migraine.
- The effect of Drugs on hyperactivity in children with some observations of changes in mineral metabolism.
- The cost consequences of pharmacy reorganization.
- Recent developments in antidepressant agents.
- Spontaneous Opiate Addiction in Rhesus Monkeys.
- EFFECTS OF CHLORPROMAZINE ON CARDIOVASCULAR RESPONSES TO EPINEPHRINE IN SURGICAL AND PSYCHIATRIC PATIENTS.
- Fluvoxamine for children and adolescents with obsessive-compulsive Disorder: a randomized, controlled, multicenter trial.
- Fluvoxamine maleate in the treatment of depression: a single-center, double-blind, placebo-controlled comparison with imipramine in outpatients.
- A controlled trial of benzoctamine (Ba-30803) in neurotic Anxiety.
- Sertraline safety and efficacy in major depression: a double-blind fixed-dose comparison with placebo.
- A comparison of paroxetine and placebo in depressed outpatients.
- New antidepressants.
- A double-blind comparison of paroxetine with imipramine in the long-term treatment of depression.
- A double-blind placebo-controlled study of Org 3770 in depressed outpatients.
- Regional cerebral blood flow in depression: a preliminary report.
- An overview of seventeen years of experience with dothiepin in the treatment of depression in Europe.
- How appropriate is a "medical model" in psychiatric practice?
- MAO, DBH and COMT: the effect of Anxiety.
- Raised monoamine oxidase in acute psychosis?
- Cerebral blood flow in depression.
- A multi-tiered screening system for the least restrictive setting.
- Tricyclic side effects without tricyclics in depression.
- Biofeedback control of skin temperature and cerebral blood flow in migraine.
- Directional effects of skin temperature self-regulation on regional cerebral blood flow in normal subjects and migraine patients.
- Specific and non-specific effects of skin temperature control in migraine management.
- Catecholamines and monoamine oxidase activity in Anxiety.
- Daytime sleepiness in depression.
- True and pseudo cholinesterases in depression.
- A study of physician attitude on biofeedback.
- Anxiety and platelet MAO levels after relaxation training.
- Catecholamines and migraine: evidence based on biofeedback induced changes.
- Acetylcholinesterase and pseudocholinesterase activities in Anxiety.
- Catechol-O-methyltransferase and catecholamines in Anxiety and relaxation.
- Somatic symptoms in depression and antidepressants.
- Clinical trials with new bicyclic and tetracyclic compounds: zimelidine and maprotiline [proceedings].
- Comparison of the electrocardiographic effect of dothiepin and amitriptyline.
- Multicenter placebo-controlled evaluation of nomifensine treatment in depressed outpatients.
- Kinetic evaluation of platelet monoamine oxidase following relaxation in chronic Anxiety.
- Effects of acute and chronic ethanol and dihydroergotoxine (hydergine) on neurotransmitter enzymes in brain.
- Acetyl-coenzyme A hydrolase in blood.
- Death rates in psychiatric outpatients.
- Propoxyphene hydrochloride, a Drug of abuse.
- Self administration of monor tranquilizers as a functiion of conditioning.
- Psychopharmacologic characteristics of an indole compound--molindone.
- Doxepin vs. chlordiazepoxide: a controlled comparison in neurotic outpatients.
- A clinical trial of EXP 338 in the treatment of a neurotic population.
- Combined therapy in chronic schizophrenics stabilized on phenothiazine tranquilizers and given BL-KR140 or imipramine or placebo concurrently.
- Pinoxepin vs. chlorpromazine: a double-blind comparison.
- Evaluation of therapeutic efficacy of amantadine in patients with naturally occurring A2 influenza.
- Chronic administration of d-amphetamine and chlorpromazine in rats.
- A comparative study of loxapine succinate, librium, and placebo in neurotic outpatients.
- A double-blind comparison of haloperidol (Haldol) and thioridazine (Mellaril) in outpatient children.
- Group therapy and maintenance treatment of schizophrenics.
- Reduction in hospitalization of schizophrenics.
- Nursing dress, an experimental evaluation of its effect on psychiatric patients.
- A double-blind comparison of pimozide vs. trifluoperazine in schizophrenic outpatients.
- Review of clinical and laboratory experiences with molindone hydrochloride.
- The effectiveness of 6-azamianserin (Org 3770) in depressed outpatients.
- Double-blind, multicenter comparison of sertraline and amitriptyline in elderly depressed patients.
- The safety and efficacy of paroxetine compared with placebo in a double-blind trial of depressed outpatients.
- Paroxetine versus placebo: a double-blind comparison in depressed patients.
- Skin temperature self-regulation and non-invasive regional cerebral blood flow.
- Biological symptoms of depression.
- Xerostomia and sialorrhea in depression.
- Biochemical basis for biofeedback treatment of migraine: a hypothesis.
- The effects of response bias on sex differences in a psychiatric population.
- Saliva lithium and lithium therapy.
- Craving for Alcohol in sober Alcoholics.
- Anxiety and serum prolactin.
- Dothiepin HCl in the treatment of psychoneurosis [proceedings].
- Penfluridol: a long acting oral antipsychotic Drug.
- Trends in hospital versus community treatment of mental illness: a Texas example.
Schools
Albany Medical College
Ej Meyer Meml Hospital
Cleveland Psy Institute
Conditions Treated
- Adjustment Disorder
- Anxiety
- Bipolar Disorder
- Drug and Alcohol Dependence
- View All
Doctors Specialties
- Psychiatry
Accepted Insurances
- Aetna HMO
- Choice Plus POS II
- Amerigroup (Wellpoint)
- Blue Card PPO
- Blue Choice
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- LocalPlus
- Open Access Plus
- Commercial Insurance Company
- Humana
- Medicaid
- Medicare MCR
- Priority Health
- Choice Plus POS
- Navigate POS
- Options PPO
- United Healthcare
Education
-
Albany Medical College
Helpful Reviews
Similar Doctors
|
|
Dr. Rabab Rizvi, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Robert J. Bacon Jr., MD |
|
|
Dr. Donna J. Sutter, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Louis F. Fabre Jr., MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. David Krueger, MD |
|
|
Dr. Mohsen Mirabi, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Karley Y. Little Jr., MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Thomas A. Hamlin, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mahwish M. Shakir, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ismael Carlo, MD |
|
|
Dr. Leigh E. Cunningham, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Marie A. Dewitt, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Madiha Khan, MD |
|
|
Dr. Romeo S. Yap, MD |